Breaking News

Novella Clinical Appoints Senior Medical Director

June 27, 2014

Bui to head oncology division

Lynne Bui, M.D. has been appointed senior medical director for the oncology division at Novella Clinical. Dr. Bui will be based in San Francisco and will provide medical and scientific support to clinical research programs, study teams and investigators, as well as review, advise and lead research programs.  
 
Dr. Bui is a board certified hematologist/oncologist with more than nine years of industry experience in all phases of drug development. She has worked as a medical monitor for Phase I-IV studies, where she led clinical teams and wrote protocols, investigator’s brochures, annual reports, clinical study reports and case report forms. Most recently, she served as a drug development consultant for biotechnology, medical device and pharma companies in oncology, hematology and internal medicine. 
 

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important